Market Access and HTA: What Every Pharmaceuticals Stakeholder Should Know
December 12 - 13, 2016 - Dubai CHDIA
daniel.hartman@diaglobal.org
Phone:+41612255151
Today, manufacturers face many challenges and opportunities when dealing with the innovative approaches to demonstrate a value and affordability of a pharmaceutical product to other stakeholders. Key elements for successful delivery of value and affordability include market access and HTA (Health Technology Assessment).
This website uses cookies to ensure you get the best experience on our website. Learn more